PT97743A - Processo para a preparacao de composicoes farmaceuticas comportando baclofeno como ingrediente activo destinadas ao tratamento da angina de peito - Google Patents

Processo para a preparacao de composicoes farmaceuticas comportando baclofeno como ingrediente activo destinadas ao tratamento da angina de peito

Info

Publication number
PT97743A
PT97743A PT97743A PT9774391A PT97743A PT 97743 A PT97743 A PT 97743A PT 97743 A PT97743 A PT 97743A PT 9774391 A PT9774391 A PT 9774391A PT 97743 A PT97743 A PT 97743A
Authority
PT
Portugal
Prior art keywords
baclofen
treatment
behavioring
angine
breast
Prior art date
Application number
PT97743A
Other languages
English (en)
Other versions
PT97743B (pt
Inventor
Pascal-Pierre Bousquet
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of PT97743A publication Critical patent/PT97743A/pt
Publication of PT97743B publication Critical patent/PT97743B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT97743A 1990-05-23 1991-05-22 Processo para a preparacao de composicoes farmaceuticas comportando baclofeno como ingrediente activo destinadas ao tratamento da angina de peito PT97743B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9006437A FR2662354B1 (fr) 1990-05-23 1990-05-23 Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine.

Publications (2)

Publication Number Publication Date
PT97743A true PT97743A (pt) 1992-02-28
PT97743B PT97743B (pt) 1998-10-30

Family

ID=9396882

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97743A PT97743B (pt) 1990-05-23 1991-05-22 Processo para a preparacao de composicoes farmaceuticas comportando baclofeno como ingrediente activo destinadas ao tratamento da angina de peito

Country Status (15)

Country Link
US (1) US5149713A (pt)
EP (1) EP0458699B1 (pt)
JP (1) JPH0717502B2 (pt)
AT (1) ATE116848T1 (pt)
AU (1) AU635418B2 (pt)
CA (1) CA2043033C (pt)
DE (1) DE69106586T2 (pt)
DK (1) DK0458699T3 (pt)
ES (1) ES2069843T3 (pt)
FR (1) FR2662354B1 (pt)
GR (1) GR3015513T3 (pt)
IE (1) IE65575B1 (pt)
OA (1) OA09498A (pt)
PT (1) PT97743B (pt)
ZA (1) ZA913910B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1331965B1 (en) 2000-10-26 2008-07-16 Medtronic, Inc. Apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions
US20070191895A1 (en) * 2001-04-20 2007-08-16 Foreman Robert D Activation of cardiac alpha receptors by spinal cord stimulation produces cardioprotection against ischemia, arrhythmias, and heart failure
WO2002085448A2 (en) * 2001-04-20 2002-10-31 The Board Of Regents Of The University Of Oklahoma Cardiac neuromodulation and methods of using same
JP2004533297A (ja) 2001-05-29 2004-11-04 メドトロニック・インコーポレーテッド 心臓病の予防及び処置のための閉ループ神経調節システム
US7657482B1 (en) * 2002-07-15 2010-02-02 Paymentech, L.P. System and apparatus for transaction fraud processing
US7824697B2 (en) * 2004-07-12 2010-11-02 Board Of Regents, The University Of Texas System High concentration baclofen preparations
CA2721134C (en) 2007-06-13 2017-02-07 Wayne State University Board Of Governors A baclofen solution for low-volume therapeutic delivery
CA2721135A1 (en) 2007-06-13 2008-12-24 Wayne State University Board Of Governors A zwitterion solution for low-volume therapeutic delivery
US20150258279A1 (en) 2008-03-18 2015-09-17 Mallinckrodt Llc Intrathecal baclofen pharmaceutical dosage forms and related delivery system
US8969414B2 (en) * 2009-02-06 2015-03-03 Mallinckrodt Llc Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
US8315713B2 (en) * 2008-04-30 2012-11-20 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US8260412B2 (en) 2008-10-31 2012-09-04 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9192769B2 (en) * 2008-10-31 2015-11-24 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US8774918B2 (en) * 2008-10-31 2014-07-08 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
WO2010051486A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
US8527045B2 (en) * 2008-10-31 2013-09-03 Medtronic, Inc. Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US8611996B2 (en) 2008-10-31 2013-12-17 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8005539B2 (en) * 2008-10-31 2011-08-23 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8688210B2 (en) * 2008-10-31 2014-04-01 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9775987B2 (en) 2008-10-31 2017-10-03 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8560060B2 (en) 2008-10-31 2013-10-15 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US8452394B2 (en) 2008-10-31 2013-05-28 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9597505B2 (en) * 2008-10-31 2017-03-21 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8249708B2 (en) * 2008-10-31 2012-08-21 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8498698B2 (en) 2008-10-31 2013-07-30 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US8532779B2 (en) * 2008-10-31 2013-09-10 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
CA2874737A1 (en) 2012-06-01 2013-12-05 Lynn Health Science Institute, Inc. Use of baclofen to treat insomnia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449046A (de) * 1963-07-09 1967-12-31 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
GB1547609A (en) * 1975-04-28 1979-06-20 Nelson Res & Dev Potentiated hypotensive composition
US4084000A (en) * 1975-07-16 1978-04-11 Nelson Research And Development Company Method of treating schizophrenia
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
NL7706429A (nl) * 1977-06-10 1978-12-12 Univ Erasmus Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents

Also Published As

Publication number Publication date
FR2662354A1 (fr) 1991-11-29
EP0458699B1 (fr) 1995-01-11
OA09498A (fr) 1992-11-15
DE69106586D1 (de) 1995-02-23
US5149713A (en) 1992-09-22
ES2069843T3 (es) 1995-05-16
GR3015513T3 (en) 1995-06-30
DK0458699T3 (da) 1995-06-12
JPH04226914A (ja) 1992-08-17
IE65575B1 (en) 1995-11-01
AU635418B2 (en) 1993-03-18
CA2043033A1 (fr) 1991-11-24
ATE116848T1 (de) 1995-01-15
EP0458699A2 (fr) 1991-11-27
FR2662354B1 (fr) 1994-10-07
PT97743B (pt) 1998-10-30
AU7619291A (en) 1991-11-28
ZA913910B (en) 1992-02-26
CA2043033C (fr) 1998-09-29
EP0458699A3 (en) 1992-03-04
IE911742A1 (en) 1991-12-04
JPH0717502B2 (ja) 1995-03-01
DE69106586T2 (de) 1995-07-06

Similar Documents

Publication Publication Date Title
PT97743A (pt) Processo para a preparacao de composicoes farmaceuticas comportando baclofeno como ingrediente activo destinadas ao tratamento da angina de peito
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
PT91246A (pt) Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2044912T3 (es) Composiciones farmaceuticas dotadas de actividad secuestrante para los acidos biliares, conteniendo colestiramina como principio activo, y procedimiento para su preparacion.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
DE69732170D1 (de) Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
MX9100160A (es) Procedimiento para preparar un medicamento que contiene flupirtina como sustancia activa para combatir contracturas musculares
ES2178037T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
ATE382051T1 (de) Prodrugs von pharmazeutika mit erhöhter bioverfügbarheit
PT97905A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cistina
PT92949A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cisteina para o tratamento de doencas associadas com infeccoes provocadas por virus da imunodeficiencia humano
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
AR005970A1 (es) Compuestos de benzotiofeno y formulaciones farmaceuticas que los contienen como agente activo
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
PT98532A (pt) Processo para a preparacao de formulacoes solidas para aplicacao oral contendo como ingrediente activo ifosfamida
ES2180750T3 (es) Conjugado de un principio activo, un polieter y, en caso dado, una proteina nativa no considerada como exogena.
PT95810A (pt) Processo para a preparacao de composicoes farmaceuticas injectaveis contendo um alcaloide de bis-indol como ingrediente activo
MX6274E (es) Procedimiento para la preparacion de composiciones parmaceuticas que contienen alcohilantes citostaticos destoxificados
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911029

FG3A Patent granted, date of granting

Effective date: 19980706

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020131